Global Serum Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Serum Market Size

• The global serum market was valued at USD 1.57 billion in 2024 and is expected to reach USD 3.37 billion by 2032
• During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 10.00%, primarily driven by the increasing demand for diagnostic and therapeutic application.
• This growth is driven by factors such as rising health expenditure, increasing prevalence of chronic disease, and advancements in technology

Serum Market Analysis

• Serum products are vital in various healthcare applications, including diagnostics, therapeutic treatments, and research. They are essential in the preparation of vaccines, biologics, and in-vitro diagnostic assays, as well as being used for the cultivation of cells in biotechnology and regenerative medicine
• The demand for serum is primarily driven by the increasing prevalence of chronic diseases, rising healthcare needs, and advancements in biotechnology and pharmaceutical research. The growing adoption of serum in clinical trials and the rise in stem cell therapies are significantly boosting the market
• North America is one of the dominant regions in the global serum market, driven by its advanced healthcare infrastructure, high spending on research and development, and robust pharmaceutical and biotechnology sectors. The demand for serum-based products in diagnostics and therapeutic applications is particularly high in the U.S. due to the country's leading role in medical research and healthcare innovation
• Globally, serum products rank as one of the most critical components in laboratory testing, research, and treatment development. With the increasing focus on personalized medicine and the expansion of clinical trials, the role of serum in ensuring effective diagnostic outcomes and therapeutic solutions continues to grow

Report Scope and Serum Market Segmentation      

Serum Market Trends

“Increasing Adoption of Automation and Artificial Intelligence (AI)”

• One prominent trend in the global serum market is the growing adoption of automation and artificial intelligence (AI) technologies
• These advanced technologies enhance the efficiency and accuracy of serum production, processing, and testing by automating repetitive tasks, reducing human error, and improving throughput in laboratories and manufacturing facilities
  • For instance, AI-powered systems are being used for serum quality control, where machine learning algorithms analyze large datasets to predict and detect potential issues, ensuring consistent and high-quality serum products
• Automation also streamlines the serum-based diagnostic processes, reducing turnaround time for results and improving the speed of diagnostic testing, which is crucial for rapid patient care
• This trend is revolutionizing the serum market, optimizing production processes, increasing scalability, and improving the overall quality and accessibility of serum products across various healthcare sectors

Serum Market Dynamics

Driver

“Growing Demand Due to Prevalence of Chronic Diseases”

• The rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer is significantly driving the demand for serum products globally
• As the global population ages and the incidence of these diseases increases, the need for serum-based diagnostic tests and therapeutic solutions grows, with serum being a vital component in detecting and managing these conditions
• Serum is crucial for diagnosing infections, monitoring disease progression, and detecting biomarkers in patients with chronic conditions, making it an indispensable tool in healthcare
• The increasing focus on personalized medicine, where serum biomarkers are used to tailor treatments to individual patients, further contributes to the expanding demand for high-quality serum products
• With the growing need for early disease detection and better treatment options, the demand for serum-based diagnostics is expected to rise significantly, ensuring improved health outcomes and more efficient healthcare delivery

For instance,

• In 2023, according to a study published in the Journal of Clinical Diagnostics, the rising prevalence of diabetes worldwide, particularly in individuals aged 40 and above, has created a significant demand for serum-based tests to manage blood glucose levels and detect diabetic complications. This trend is driving the global serum market
• In 2024, a report by the World Health Organization noted that cardiovascular diseases are the leading cause of death globally, leading to increased demand for serum-based testing to monitor cholesterol, lipids, and other cardiovascular markers 
• The growing prevalence of chronic diseases and the increasing demand for personalized medicine are key factors driving the global serum market, enhancing diagnostic accuracy and improving patient care outcomes

Opportunity

“Advancements in AI and Automation in Serum Production”

• The integration of artificial intelligence (AI) and automation into serum production processes is revolutionizing the market by improving efficiency, quality control, and scalability
• AI-powered systems can monitor and predict the quality of serum batches in real-time, ensuring consistent and high-quality products, reducing errors, and enhancing the overall manufacturing process
• Automation streamlines the processing and packaging of serum products, lowering production costs and increasing output, making serum products more affordable and accessible to healthcare providers globally

For instance,

• In January 2025, according to an article published in The Journal of Biotechnology, AI algorithms are being increasingly employed to monitor serum quality during the manufacturing process, helping to predict batch inconsistencies and prevent product recalls. These innovations are expected to drive growth in the global serum market
• In November 2023, Automation Today reported that automated serum processing systems are improving the speed and accuracy of serum production, which is enabling greater scalability and meeting the rising global demand for serum-based diagnostics and therapeutics 
• The integration of AI and automation in serum production is enhancing efficiency, quality, and scalability, driving growth and accessibility in the global serum market

Restraint/Challenge

“High Production Costs and Regulatory Hurdles”

• The high cost of serum production and stringent regulatory requirements pose significant challenges to the market, especially for small-scale producers and emerging market players
• Serum production, particularly from human sources, involves complex processes and strict adherence to Good Manufacturing Practices (GMP), making it a resource-intensive and costly operation
• Regulatory compliance for serum-based products, including extensive testing and certification, adds additional time and costs to product development and distribution, which may delay market entry and limit supply

For instance,

• In December 2024, according to an article published by Biopharma News, the cost of producing serum-based diagnostic tests continues to rise due to the complexities of sourcing and processing raw materials, along with the regulatory barriers that must be overcome to ensure safety and efficacy. This challenge affects pricing and accessibility in certain regions, especially in developing countries 
• These factors create a barrier to market penetration, particularly in regions with limited access to advanced manufacturing capabilities, thereby hindering the overall growth of the global serum market

Serum Market Scope

The market is segmented on the basis of type, inactivation technique, application, end user, and sales channel.

Serum Market Regional Analysis

“North America is the Dominant Region in the Serum Market”

• North America leads the global serum market, driven by its advanced healthcare infrastructure, strong regulatory frameworks, and high adoption of state-of-the-art diagnostic technologies
• U.S. holds a significant market share, fuelled by the growing demand for serum-based diagnostic tests, particularly in managing chronic diseases such as diabetes, cardiovascular conditions, and cancer. The presence of major serum producers and well-established healthcare reimbursement policies strengthens the region's market position
• In addition, the increasing prevalence of chronic diseases and the continuous advancements in personalized medicine are driving the demand for high-quality serum products
• The strong investment in research and development by leading pharmaceutical and biotechnology companies ensures continuous innovation, further solidifying North America's dominance in the global serum market

“Asia-Pacific is Projected to Register the Highest Growth Rate”

• Asia-Pacific is expected to experience the highest growth rate in the global serum market, supported by rapid advancements in healthcare infrastructure, growing awareness about disease prevention, and increasing healthcare spending
• Countries such as China, India, and Japan are emerging as key markets due to their large populations, rising prevalence of chronic diseases, and improvements in healthcare accessibility
• Japan is at the forefront, with its advanced healthcare systems and robust demand for serum-based diagnostic tests, particularly in managing conditions such as diabetes and cardiovascular diseases
• China and India, with their expanding healthcare sectors and increasing cases of chronic conditions, are seeing heightened government and private sector investments in diagnostic infrastructure, making them key contributors to the growth of the global serum market

Serum Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific Inc. (U.S.)
• Merck KGaA (Germany)
• Cytiva (U.S.)
• Bio-Techne (U.S.)
• Atlas Biologicals, Inc. (U.S.)
• Rocky Mountain Biologicals (U.S.)
• Takara Bio Inc. (Japan)
• PAN-Biotech (Germany)
• Sartorius AG (Germany)
• Corning Incorporated (U.S.)
• Bovogen Biologicals Pty Ltd. (Australia)
• Moregate Biotech (Australia)
• Biowest (France)
• Plant Cell Technology (U.S.)
• GeminiBio LLC (U.S.)
• Abbott (U.S.)

Latest Developments in Global Serum Market

• In January 2025, Thermo Fisher Scientific announced the launch of its next-generation serum testing platform, designed to enhance the accuracy and efficiency of serum-based diagnostics. The new platform integrates advanced AI algorithms for real-time analysis of biomarkers, providing faster and more reliable results for managing chronic diseases such as diabetes and cardiovascular conditions. The platform also offers customizable testing options for personalized medicine, supporting more tailored treatment regimens for patients
• In December 2024, Abbott Laboratories unveiled a new line of serum-based diagnostic assays, focusing on the early detection of multiple chronic conditions, including liver disease and cardiovascular disorders. These tests are designed to provide high sensitivity and specificity, ensuring early diagnosis and better treatment outcomes. Abbott’s innovative solutions are expected to drive significant growth in the global serum market, especially in regions with rising healthcare demands
• In November 2024, Siemens Healthineers introduced its updated serum biomarker testing system, which improves the speed and accuracy of serum analysis for oncology and infectious diseases. The system incorporates a fully automated workflow, reducing human error and enhancing laboratory productivity. This development is poised to revolutionize serum testing in clinical laboratories and hospitals, ensuring quicker diagnostic decisions for patients globally
• In September 2024, Roche Diagnostics launched a new serum-based test for cardiovascular health monitoring. The test measures multiple biomarkers simultaneously, allowing healthcare providers to better manage heart disease and related conditions. This advancement underscores the growing importance of serum diagnostics in the early detection and management of chronic conditions, further fuelling the expansion of the serum market

SKU-56873